Literature DB >> 20451375

Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity.

Harish Kommera1, Goran N Kaluderović, Sebastian Dittrich, Jutta Kalbitz, Birgit Dräger, Thomas Mueller, Reinhard Paschke.   

Abstract

Synthesis and antiproliferative activity of eight new derivatives of betulinic acid (1) and betulin (2) are described. The compounds were tested against fifteen tumor cell lines. The toxicity against normal human fibroblasts and the mode of cell death on lung cancer cell line induced by the most active compounds 9 (bis(ethylcarbamate)betulin) and 11 (3-O-ethylcarbamate of 28-O-acetylbetulin) was investigated. Caspase 3 activity on lung cancer cell line (A549) was determined for 1, 5 (3-O-ethylcarbamate of betulinic acid), 9 and 11. All derivatives exerted a dose dependent antiproliferative action at micromolar concentrations toward target tumor cell lines. Treatment of lung cancer cells for 24h with 9 and 11 induced apoptosis, as observed by the appearance of a typical ladder pattern in the DNA fragmentation assay. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451375     DOI: 10.1016/j.bmcl.2010.04.004

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Synthesis, cytotoxicity and anti-inflammatory activity of rhamnose-containing ursolic and betulinic acid saponins.

Authors:  Balla Sylla; Serge Lavoie; Jean Legault; Charles Gauthier; André Pichette
Journal:  RSC Adv       Date:  2019-12-02       Impact factor: 4.036

2.  Madecassic Acid-A New Scaffold for Highly Cytotoxic Agents.

Authors:  Oliver Kraft; Ann-Kathrin Hartmann; Sophie Hoenke; Immo Serbian; René Csuk
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

3.  Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.

Authors:  Jana Blaževski; Filip Petković; Miljana Momčilović; Reinhard Paschke; Goran N Kaluđerović; Marija Mostarica Stojković; Djordje Miljković
Journal:  Acta Pharmacol Sin       Date:  2013-02-04       Impact factor: 6.150

4.  Novel betulin derivative induces anti-proliferative activity by G2/M phase cell cycle arrest and apoptosis in Huh7 cells.

Authors:  Zhen-Jian Zhuo; Min-Jie Xiao; Hui-Ran Lin; Jing Luo; Tao Wang
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

5.  Betulinic acid shows anticancer activity against equine melanoma cells and permeates isolated equine skin in vitro.

Authors:  Lisa A Weber; Jessica Meißner; Julien Delarocque; Jutta Kalbitz; Karsten Feige; Manfred Kietzmann; Anne Michaelis; Reinhard Paschke; Julia Michael; Barbara Pratscher; Jessika-M V Cavalleri
Journal:  BMC Vet Res       Date:  2020-02-05       Impact factor: 2.741

6.  Synthesis of Four Steroidal Carbamates with Antitumor Activity against Mouse Colon Carcinoma CT26WT Cells: In Vitro and In Silico Evidence.

Authors:  Daylin Fernández Pacheco; Dayana Alonso; Leonardo González Ceballos; Armando Zaldo Castro; Sheila Brown Roldán; Mairelys García Díaz; Anabel Villa Testa; Sarah Fuentes Wagner; Janet Piloto-Ferrer; Yamilet Coll García; Andrés F Olea; Luis Espinoza
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

7.  Antiproliferative activity and apoptosis-inducing mechanism of constituents from Toona sinensis on human cancer cells.

Authors:  Shengjie Yang; Qi Zhao; Hongmei Xiang; Minjie Liu; Qiuyun Zhang; Wei Xue; Baoan Song; Song Yang
Journal:  Cancer Cell Int       Date:  2013-02-09       Impact factor: 5.722

8.  Synthesis, structure and cytotoxic activity of new acetylenic derivatives of betulin.

Authors:  Stanisław Boryczka; Ewa Bębenek; Joanna Wietrzyk; Katarzyna Kempińska; Maria Jastrzębska; Joachim Kusz; Maria Nowak
Journal:  Molecules       Date:  2013-04-17       Impact factor: 4.411

Review 9.  The Effect of Terpenoid Natural Chinese Medicine Molecular Compound on Lung Cancer Treatment.

Authors:  Heng Sun; Lijia Zhang; Bowen Sui; Yu Li; Jun Yan; Peng Wang; Ye Wang; Songjiang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-16       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.